Touyun Biotech Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11.53	16.32	34.49	128.1	60.2	142.44
Short-Term Investments	-	3.87	7.53	6.2	5.91	7.85
Trading Asset Securities	-	53.33	1.54	16.16	33.76	111.96
Cash & Short-Term Investments	11.53	73.51	43.56	150.45	99.87	262.24
Cash Growth	-16.22%	68.75%	-71.05%	50.65%	-61.92%	27.47%
Accounts Receivable	12.27	22.28	27.14	41.45	66.29	58.69
Other Receivables	28.95	27.28	27.28	26.49	26.13	10.35
Receivables	43.67	64.8	96.97	131.96	132.46	170.66
Inventory	17.23	24.59	15.25	35.61	32.77	33.74
Prepaid Expenses	49.52	4.21	2.87	3.99	3.12	1.87
Other Current Assets	-	6.94	3.83	-	-	-
Total Current Assets	121.95	174.05	162.48	322.01	268.22	468.51
Property, Plant & Equipment	267.84	280.18	310.63	381.28	435.95	172.2
Long-Term Investments	223.24	95.9	134.03	184.13	318.94	320.69
Goodwill	-	-	-	-	-	0.51
Other Intangible Assets	-	-	-	0.28	0.66	7.73
Long-Term Deferred Charges	-	-	-	-	0.97	2.31
Total Assets	613.22	550.32	607.34	887.7	1,025	971.94
Accounts Payable	6.74	12.53	17.96	28.32	37.88	29.97
Accrued Expenses	17.16	18.89	16.91	15.49	12.15	13.89
Short-Term Debt	99.49	99.36	94.39	284.35	388.87	186.95
Current Portion of Long-Term Debt	389.56	339.32	164.89	-	-	112.23
Current Portion of Leases	6.4	10.13	14.46	12	14.41	14.25
Current Income Taxes Payable	0.17	0.17	0.51	4.14	2.17	4.49
Current Unearned Revenue	11.48	22.16	18.88	17.18	23.48	28.08
Other Current Liabilities	83.63	55.44	52.7	48.51	50.61	17.62
Total Current Liabilities	614.62	557.98	380.71	410	529.56	407.48
Long-Term Debt	3.81	26.81	191.45	191.29	-	-
Long-Term Leases	0.95	6.17	14.1	2.9	8.12	8.09
Total Liabilities	619.38	590.96	586.27	604.19	537.68	415.57
Common Stock	112.24	112.24	112.24	112.24	112.24	110.95
Additional Paid-In Capital	1,908	1,908	1,908	1,908	1,908	1,876
Retained Earnings	-2,117	-2,137	-2,061	-1,801	-1,608	-1,539
Comprehensive Income & Other	33.15	34.07	39.92	45.27	58.52	40.05
Total Common Equity	-63.84	-83.2	-0.85	263.96	469.92	488.04
Minority Interest	57.67	42.56	21.92	19.55	17.13	68.33
Shareholders' Equity	-6.17	-40.64	21.07	283.51	487.05	556.37
Total Liabilities & Equity	613.22	550.32	607.34	887.7	1,025	971.94
Total Debt	500.21	481.78	479.3	490.55	411.41	321.52
Net Cash (Debt)	-488.68	-408.27	-435.74	-340.1	-311.54	-59.28
Net Cash Per Share	-0.17	-0.15	-0.16	-0.12	-0.11	-0.02
Filing Date Shares Outstanding	2,806	2,806	2,806	2,806	2,806	2,774
Total Common Shares Outstanding	2,806	2,806	2,806	2,806	2,806	2,774
Working Capital	-492.67	-383.93	-218.23	-87.99	-261.34	61.03
Book Value Per Share	-0.02	-0.03	-0.00	0.09	0.17	0.18
Tangible Book Value	-63.84	-83.2	-0.85	263.68	469.26	479.81
Tangible Book Value Per Share	-0.02	-0.03	-0.00	0.09	0.17	0.17
Buildings	-	175.81	174.32	167.34	-	-
Machinery	-	169.74	175.68	175.55	77.24	75.06
Construction In Progress	-	2.4	5.81	0.65	310.85	133.08
Leasehold Improvements	-	5.19	5.41	5.33	5.37	5.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.